Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis

被引:24
|
作者
Lingscheid, Tilman [1 ,2 ,3 ]
Kinzig, Martina [4 ]
Krueger, Anne [2 ,3 ,5 ]
Mueller, Nils [2 ,3 ,5 ]
Boelke, Georg [2 ,3 ,5 ]
Tober-Lau, Pinkus [1 ,2 ,3 ]
Muenn, Friederike [1 ,2 ,3 ]
Kriedemann, Helene [1 ,2 ,3 ]
Witzenrath, Martin [1 ,2 ,3 ,6 ]
Sander, Leif E. [1 ,2 ,3 ,6 ,7 ]
Soergel, Fritz [4 ,8 ]
Kurth, Florian [1 ,2 ,3 ,9 ]
机构
[1] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] IBMP Inst Biomed & Pharmaceut Res, Nurnberg, Germany
[5] Charite Univ Med Berlin, Dept Nephrol & Intens Care, Berlin, Germany
[6] DZL, German Ctr Lung Res, Berlin, Germany
[7] Berlin Inst Hlth, Berlin, Germany
[8] Univ Duisburg Essen, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany
[9] Bernhard Nocht Inst Trop Med, Dept Trop Med, Hamburg, Germany
关键词
COVID-19; end-stage renal disease; hemodialysis; nirmatrelvir/ritonavir; Paxlovid; PLASMA;
D O I
10.1128/aac.01229-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nirmatrelvir/ritonavir is an effective antiviral therapy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Use is not recommended in patients with end-stage renal disease (ESDR) due to a lack of data. We investigated the pharmacokinetics of nirmatrelvir/ritonavir (150 mg/100 mg twice a day) in four patients with ESRD undergoing hemodialysis. Nirmatrelvir peak concentrations ranged from 4,563 to 7,898 ng/ mL and declined after hemodialysis. Concentrations were up to 4-fold higher but still within the range known from patients without ESRD, without accumulation of nirmatrelvir after the end of treatment.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis
    Dembowska, Elzbieta
    Jaron, Aleksandra
    Gabrysz-Trybek, Ewa
    Bladowska, Joanna
    Gacek, Szymon
    Trybek, Grzegorz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [32] Subdural hematoma in patients with end-stage renal disease receiving hemodialysis
    Wang, I. -K.
    Lin, C. -L.
    Wu, Y. -Y.
    Kuo, H. -L.
    Lin, S. -Y.
    Chang, C. -T.
    Yen, T. -H.
    Chuang, F. -R.
    Cheng, Y. -K.
    Huang, C. -C.
    Sung, F. -C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 894 - 900
  • [33] Ocular changes during hemodialysis in patients with end-stage renal disease
    Hejun Chen
    Xi Zhang
    Xi Shen
    BMC Ophthalmology, 18
  • [34] Predictors of quality of life in patients with end-stage renal disease on hemodialysis
    Saad, Marc M.
    El Douaihy, Youssef
    Boumitri, Christine
    Rondla, Chetana
    Moussaly, Elias
    Daoud, Magda
    El Sayegh, Suzanne E.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2015, 8 : 119 - 123
  • [35] Comparison of Azvudine and Nirmatrelvir/ Ritonavir and Combined Use in Patients with COVID-19
    Hu, Cheng-Yi
    Cui, Wen-Shuai
    Lei, Yi
    Tang, Yu-Wen
    Zhang, Yan-Yan
    Su, Qi-Min
    Peng, Fang
    Zeng, Yun-Fei
    Song, Jia-Lin
    Luo, Cheng-Na
    Zhou, Yan
    Li, Xin-Yan
    Zhao, Zhu-Xiang
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 7797 - 7808
  • [36] Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis
    Luiz Derwal Salles Junior
    Paulo Roberto Santos
    Armênio Aguiar dos Santos
    Marcellus Henrique Loiola Ponte de Souza
    BMC Nephrology, 14
  • [37] Symptom Clusters in Patients with End-Stage Renal Disease Undergoing Hemodialysis
    Chaiviboontham, Suchira
    Phinitkhajorndech, Noppawan
    Tiansaard, Juthamas
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2020, 13 : 297 - 305
  • [38] Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis
    Van Buren, Peter Noel
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [39] Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis
    Peter Noel Van Buren
    Current Cardiology Reports, 2016, 18
  • [40] High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort
    Toro, Luis
    Michea, Luis
    Parra-Lucares, Alfredo
    Mendez-Valdes, Gabriel
    Villa, Eduardo
    Bravo, Ignacio
    Pumarino, Catalina
    Ayala, Patricia
    Sanhueza, Maria Eugenia
    Torres, Ruben
    Elgueta, Leticia
    Chavez, Sebastian
    Rojas, Veronica
    Alvo, Miriam
    TOXINS, 2023, 15 (02)